Treatment of stiff person syndrome with rituximab.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15965211.
- Also identified by PMC identifier 1739691.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case report is about the novel use of the anti-CD20 antibody, rituximab, in the treatment of a 41 year old woman with stiff person syndrome. She was admitted to hospital as an emergency with prolonged and painful extensor spasms affecting the neck and back, arms, and legs. The disease had progressed despite a favourable initial response to conventional treatment with intravenous immunoglobulin and cytotoxics. Treatment with rituximab induced a lasting clinical remission.
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Immunologic Factors
- Mycophenolic Acid
- Stiff-Person Syndrome